Back to announcement
20251208_SDPC_Laporan Informasi dan Fakta Material_32011252_lamp1.pdf
Other Text extracted SDPCSource file signed link, expires in 15 minutes
Extracted text 2
Page 1 OCR 0.933
oma PT MILLENNIUM PHARMACON INTERNATIONAL Tbk Jakarta, 8 Desember 2025 No. 1098/MPI/DIR/XII/2025 Lampiran : - Perihal Laporan Informasi atau Fakta Material Yth. Kepala Eksekutif Pengawas Pasar Modal Otoritas Jasa Keuangan Gedung Soemitro Djojohadikusumo Jalan Lapangan Banteng Timur 2-4 Jakarta 10710 Sehubungan dengan Peraturan Otoritas Jasa Keuangan (OJK) no: 45 Tahun 2024 tanggal 31 Desember 2024 tentang Tentang Pengembangan dan Penguatan Emiten dan Perusahaan Publik, dengan ini kami menyampaikan Laporan Informasi atau Fakta Material sebagai berikut : In reference to Otoritas Jasa Keuangan (OJK) Regulation No.: 45 of 2024 dated 31 December 2024 regarding DDevelopment and Strengthening of Issuers and Public Companies, we hereby disclose the information and Material Fact as follow: Nama Emiten atau Perusahaan Publik//ssuer : Bidang Usaha/Scope of Business Telepon/Phone Faksimili/Facsimile Alamat surat elektronik/e-mail PT Millennium Pharmacon International Tbk (“Perseroan”) Distribusi produk farmasi, suplemen makanan dan alat kesehatan (021) 2708 5961, (021) 2708 5964 (021) 2708 5958 investor.relation@mpi-pharmaniaga.co.id 1 | Tanggal kejadian 8 Desember 2025 Date Event Desember 8", 2025 2 | Jenis Informasi atau Fakta Material Perpanjangan Fasilitas Pinjaman Type of Information or Material Facts The renewal of loan facility 3 | Uraian Informasi atau Fakta Material Perseroan dan PT CIMB Niaga Tbk, b) Bank telah menyetujui Rp300 Miliar kepada Perseroan, bulan. a) Pihak-pihak yang melakukan perjanjian: perpanjangan fasilitas kredit dengan total limit sejumlah c) Jangka waktu fasilitas adalah 12 (dua belas) Description of Information or Material Facts ga) Parties to the agreement : Company and PT Bank CIMB Niaga Tbk, b) The Bank has approved the renewal of the credit facilities with total limit facility amounted to IDR300 billion to the company, c) The facility tenor is 12 (twelve) months. Crown Bungur Arteri 2-4th Floors Jl. Sultan Iskandar Muda No. 18, Jakarta 12240, Indonesia Phone : #6221 27085961
Page 2 OCR 0.916
PT MILLENNIUM PHARM., IACON INTERNATIONAL Tbk Dampak kejadian, informasi atau fakta material tersebut terhada kegiatan operasional, hukum, kondisi keuangan, atau kelangsungan usaha Emiten atau Perusahaan Publik Fasilitas Kredit ini menunjang kegiatan usaha perseroan. Impact for such information or material fact towards operational activity, legal, financial condition or business continuity of Issuer or Public Company This Credit Facility supports the company's business activities. Keterangan lain-lain Tidak ada Other Information None Hormat kami, PT Millennium Pharmacon International Tbk AON WTERNATONAL TOK Nama: Ahmad bin| Abu Bakar Jabatan: Direktur Utama Tembusan: PT Bursa Efek Indonesia u.p. Yth. Direksi Crown Bungur Arteri 2-4th Floors Jl. Sultan Iskandar Muda No. 18, Jakarta 12240, Indonesia Phone : #6221 27085961
Names mentioned 9 people and organisations named in the text · linked when the evidence is strong
unresolved
org
PT CIMB Niaga Tbk
p.1
unresolved
org
Niaga Tbk
p.1
unresolved
org
PT MILLENNIUM PHARM.
p.2
unresolved
org
IACON INTERNATIONAL Tbk
p.2
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.